Dr. Reddy's Announces Filing of Three NDAs With FDA By: Benzinga via Benzinga April 08, 2015 at 05:20 AM EDT Dr. Reddy's Laboratories (NYSE: RDY) and its subsidiary, Promius Pharma, LLC today announced the filing of three 505(b)(2) New Drug ... Read More >> Related Stocks: Dr. Reddy's Laboratories Ltd ADR